Javier Iglesias-González

Javier Iglesias-González

Auto-generated profile, based on publicly available information

Javier Iglesias-González

Laboratory of Neurochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BSBernd Schöpf
Bernd Schöpf
Hansi WeissensteinerHansi Weissensteiner
Hansi Weissensteiner
GSGeorg Schäfer
Georg Schäfer
FFFederica Fazzini
Federica Fazzini
PCPornpimol Charoentong
Pornpimol Charoentong
HKHelmut Klocker
Helmut Klocker
Rewiring of energy metabolism and adaptation of mitochondria are considered to impact on prostate cancer development and progression. Here, we report on mitochondrial respiration, DNA mutations and gene expression in paired benign/malignant human prostate tissue samples. Results reveal reduced respiratory capacities with NADH-pathway substrates glutamate and malate in malignant tissue and a significant metabolic shift towards higher succinate oxidation, particularly in high-grade tumors. The load of potentially deleterious mitochondrial-DNA mutations is higher in tumors and associated with unfavorable risk factors. High levels of potentially deleterious mutations in mitochondrial Complex I-encoding genes are associated with a 70% reduction in NADH-pathway capacity and compensation by increased succinate-pathway capacity. Structural analyses of these mutations reveal amino acid alterations leading to potentially deleterious effects on Complex I, supporting a causal relationship. A metagene signature extracted from the transcriptome of tumor samples exhibiting a severe mitochondrial phenotype enables identification of tumors with shorter survival times.

20 October 2016 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
RVRita Valenzuela
Rita Valenzuela
MCMaria A Costa-Besada
Maria A Costa-Besada
JIJavier Iglesias-Gonzalez
Javier Iglesias-Gonzalez
EPEmma Perez-Costas
Emma Perez-Costas
BVBegoña Villar-Cheda
Begoña Villar-Cheda
JLJose Luis Labandeira-Garcia
Jose Luis Labandeira-Garcia
The renin–angiotensin system (RAS) was initially considered as a circulating humoral system controlling blood pressure, being kidney the key control organ. In addition to the ‘classical’ humoral RAS, a second level in RAS, local or tissular RAS, has been identified in a variety of tissues, in which local RAS play a key role in degenerative and aging-related diseases. The local brain RAS plays a major role in brain function and neurodegeneration. It is normally assumed that the effects are mediated by the cell-surface-specific G-protein-coupled angiotensin type 1 and 2 receptors (AT1 and AT2). A combination of in vivo (rats, wild-type mice and knockout mice) and in vitro (primary mesencephalic cultures, dopaminergic neuron cell line cultures) experimental approaches (confocal microscopy, electron microscopy, laser capture microdissection, transfection of fluorescent-tagged receptors, treatments with fluorescent angiotensin, western blot, polymerase chain reaction, HPLC, mitochondrial respirometry and other functional assays) were used in the present study. We report the discovery of AT1 and AT2 receptors in brain mitochondria, particularly mitochondria of dopaminergic neurons. Activation of AT1 receptors in mitochondria regulates superoxide production, via Nox4, and increases respiration. Mitochondrial AT2 receptors are much more abundant and increase after treatment of cells with oxidative stress inducers, and produce, via nitric oxide, a decrease in mitochondrial respiration. Mitochondria from the nigral region of aged rats displayed altered expression of AT1 and AT2 receptors. AT2-mediated regulation of mitochondrial respiration represents an unrecognized primary line of defence against oxidative stress, which may be particularly important in neurons with increased levels of oxidative stress such as dopaminergic neurons. Altered expression of AT1 and AT2 receptors with aging may induce mitochondrial dysfunction, the main risk factor for neurodegeneration.

1 January 2018 in Cell Reports
Verified
Journal Article
Open access
YHYue Han
Yue Han
SIShoko Ishibashi
Shoko Ishibashi
JIJavier Iglesias-Gonzalez
Javier Iglesias-Gonzalez
YCYaoyao Chen
Yaoyao Chen
NLNick R. Love
Nick R. Love
EAEnrique Amaya
Enrique Amaya
While it is appreciated that reactive oxygen species (ROS) can act as second messengers in both homeostastic and stress response signaling pathways, potential roles for ROS during early vertebrate development have remained largely unexplored. Here, we show that fertilization in Xenopus embryos triggers a rapid increase in ROS levels, which oscillate with each cell division. Furthermore, we show that the fertilization-induced Ca2+ wave is necessary and sufficient to induce ROS production in activated or fertilized eggs. Using chemical inhibitors, we identified mitochondria as the major source of fertilization-induced ROS production. Inhibition of mitochondrial ROS production in early embryos results in cell-cycle arrest, in part, via ROS-dependent regulation of Cdc25C activity. This study reveals a role for oscillating ROS levels in early cell cycle regulation in Xenopus embryos.

7 April 2009 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
Sofía Sánchez-IglesiasSofía Sánchez-Iglesias
Sofía Sánchez-Iglesias
EMEstefanía Méndez-Álvarez
Estefanía Méndez-Álvarez
JIJavier Iglesias‐González
Javier Iglesias‐González
Ana M Muñoz PatiñoAna M Muñoz Patiño
Ana M Muñoz Patiño
ISInés Sánchez-Sellero
Inés Sánchez-Sellero
RSRamón Soto-Otero
Ramón Soto-Otero
J. Neurochem. (2009) 109, 879–888. The ability of aluminium to affect the oxidant status of specific areas of the brain (cerebellum, ventral midbrain, cortex, hippocampus, striatum) was investigated in rats intraperitoneally treated with aluminium chloride (10 mg Al3+/kg/day) for 10 days. The potential of aluminium to act as an etiological factor in Parkinson’s disease (PD) was assessed by studying its ability to increase oxidative stress in ventral midbrain and striatum and the striatal dopaminergic neurodegeneration induced by 6‐hydroxydopamine in an experimental model of PD. The results showed that aluminium caused an increase in oxidative stress (TBARS, protein carbonyl content, and protein thiol content) for most of the brain regions studied, which was accompanied by a decrease in the activity of some antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase). However, studies in vitro confirmed the inability of aluminium to affect the activity of those enzymes. The reported effects exhibited a regional‐selective behaviour for all the cerebral structures studied. Aluminium also enhanced the ability of 6‐hydroxydopamine to cause oxidative stress and neurodegeneration in the dopaminergic system, which confirms its potential as a risk factor in the development of PD.

1 December 2007 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
Sofía Sánchez-IglesiasSofía Sánchez-Iglesias
Sofía Sánchez-Iglesias
RSRamón Soto-Otero
Ramón Soto-Otero
JIJavier Iglesias-González
Javier Iglesias-González
MBMaría Del Carmen Barciela-Alonso
María Del Carmen Barciela-Alonso
PBPilar Bermejo-Barrera
Pilar Bermejo-Barrera
EMEstefanía Méndez-Álvarez
Estefanía Méndez-Álvarez

22 July 2012 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
JIJavier Iglesias-González
Javier Iglesias-González
Sofía Sánchez-IglesiasSofía Sánchez-Iglesias
Sofía Sánchez-Iglesias
EMEstefanía Méndez-Álvarez
Estefanía Méndez-Álvarez
SRSarah Rose
Sarah Rose
AHAtsuko Hikima
Atsuko Hikima
RSRamón Soto-Otero
Ramón Soto-Otero